| 2024 | | Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations | 김대중, 하경화 |
| 2023 | | Impact of prolonged carbapenem use-focused antimicrobial stewardship on antimicrobial consumption and factors affecting acceptance of recommendations: a quasi-experimental study | 김영롱, 김은진, 유진세, 최영화, 하경화, 허중연 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia | 김대중, 하경화 |
| 2023 | | Long-term Effectiveness of the National Diabetes Quality Assessment Program in South Korea | 김대중, 하경화 |
| 2023 | | Diet quality partially mediates the association between ultraprocessed food consumption and adiposity indicators | 김대중, 하경화 |
| 2023 | | Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study | 김대중, 하경화, 한승진 |
| 2023 | | Ultra-Processed Food Consumption and Obesity in Korean Adults | 김대중, 하경화 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | 김대중, 하경화 |
| 2023 | | Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
| 2022 | | Association of prediabetes with death and diabetic complications in older adults: The pros and cons of active screening for prediabetes | 김대중, 하경화 |
| 2022 | | Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes | 김대중, 하경화 |
| 2022 | | Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study | 김대중, 하경화 |
| 2022 | | Association between Metabolically Healthy Obesity and Subclinical Atherosclerosis in the Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) Cohort | 김대중, 하경화 |
| 2022 | | Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study | 김대중, 하경화 |
| 2022 | | Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data | 김대중, 하경화 |
| 2022 | | Temporal Association of Total Serum Cholesterol and Pancreatic Cancer Incidence | 하경화 |
| 2022 | | Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study | 김대중, 김은진, 정윤정, 최영화, 하경화, 허중연 |
| 2022 | | Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real-world clinical practice in Korea: A national observational cohort study | 김대중, 최용준, 하경화 |
| 2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia | 김대중, 하경화 |
